Search research articles
Contact Us
Filters
Showing results (21-30 of 112) with videos related to
Page
of 12
Sort By:
Respiration; International Review of Thoracic Diseases
|
March 6, 2008
Cough efficacy is related to the disability status in patients with multiple sclerosis
Marina Aiello, Anais Rampello, Franco Granella, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 26, 2020
Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases
Giacomo Boffa, Elvira Sbragia, Anna Maria Raiola, et al.
Current Neuropharmacology
|
October 25, 2023
Ocrelizumab Extended Interval Dosing in Primary Progressive Multiple Sclerosis: An Italian Experience
Aurora Zanghì, Diana Ferraro, Graziella Callari, et al.
Journal of Neurology
|
September 16, 2023
Intravenous or subcutaneous natalizumab in patients with relapsing-remitting multiple sclerosis: investigation on efficiency and savings-the EASIER study
Massimo Filippi, Luigi Grimaldi, Antonella Conte, et al.
The Journal of Headache and Pain
|
September 26, 2008
Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium
Luigi Alberto Pini, Enrico Del Bene, Giorgio Zanchin, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|
November 2, 2011
Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial
Claudia Borreani, Andrea Giordano, Monica Falautano, et al.
Journal of Neurology
|
November 20, 2023
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients
Alvino Bisecco, Federica Matrone, Marco Capobianco, et al.
Current Medical Research and Opinion
|
May 17, 2014
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: results from an observational study
Eleonora Baldi, Angelica Guareschi, Francesca Vitetta, et al.
Journal of Neurology
|
February 5, 2013
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study
Roberto D'Alessandro, Luca Vignatelli, Alessandra Lugaresi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
September 27, 2018
Health-related quality of life in clinically isolated syndrome and risk of conversion to multiple sclerosis
Elisa Baldin, Trond Riise, Katia Mattarozzi, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 112) with videos related to
Sort By:
Page
of 12
Respiration; International Review of Thoracic Diseases
|
March 6, 2008
Cough efficacy is related to the disability status in patients with multiple sclerosis
Marina Aiello, Anais Rampello, Franco Granella, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 26, 2020
Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases
Giacomo Boffa, Elvira Sbragia, Anna Maria Raiola, et al.
Current Neuropharmacology
|
October 25, 2023
Ocrelizumab Extended Interval Dosing in Primary Progressive Multiple Sclerosis: An Italian Experience
Aurora Zanghì, Diana Ferraro, Graziella Callari, et al.
Journal of Neurology
|
September 16, 2023
Intravenous or subcutaneous natalizumab in patients with relapsing-remitting multiple sclerosis: investigation on efficiency and savings-the EASIER study
Massimo Filippi, Luigi Grimaldi, Antonella Conte, et al.
The Journal of Headache and Pain
|
September 26, 2008
Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium
Luigi Alberto Pini, Enrico Del Bene, Giorgio Zanchin, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|
November 2, 2011
Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial
Claudia Borreani, Andrea Giordano, Monica Falautano, et al.
Journal of Neurology
|
November 20, 2023
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients
Alvino Bisecco, Federica Matrone, Marco Capobianco, et al.
Current Medical Research and Opinion
|
May 17, 2014
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: results from an observational study
Eleonora Baldi, Angelica Guareschi, Francesca Vitetta, et al.
Journal of Neurology
|
February 5, 2013
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study
Roberto D'Alessandro, Luca Vignatelli, Alessandra Lugaresi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
September 27, 2018
Health-related quality of life in clinically isolated syndrome and risk of conversion to multiple sclerosis
Elisa Baldin, Trond Riise, Katia Mattarozzi, et al.
Page
of 12